Renuka Gadde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Renuka Gadde has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Andre Trollip
Fdn Innovat New Diagnost FIND South Africa, Cape Town, South Africa
1 shared publication - Andrew Whitelaw
Affiliations Division of Medical Microbiology and Immunology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa
1 shared publication - Dawit A. Wendifraw
Ethiopian Publ Hlth Inst, Natl Clin Bacteriol & Mycol Reference Lab, Addis Ababa, Ethiopia
1 shared publication - Grace Najjuka
Department of National Health Laboratories and Diagnostics Services, Central Public Health Laboratories, Ministry of Health, Uganda
1 shared publication - Heidi Albert
FIND South Africa, Cape Town, South Africa
1 shared publication - Ibrahimm Mugerwa
Department of National Health Laboratories and Diagnostics Services, Central Public Health Laboratories, Ministry of Health, Uganda
1 shared publication
Latest Publications
- Open Access
- 27 May 2022
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 11 (1) , 3
To break the cycle of COVID-19 lockdowns and safely open up economies, we must ensure equitable access to diagnosis and treatment
The African Journal of Laboratory Medicine focuses on the role of the laboratory and its professionals in the clinical and public healthcare sectors, and is specifically based on an African frame of reference.
- 27 May 2022
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 11 (1) , 3
Open AccessTo break the cycle of COVID-19 lockdowns and safely open up economies, we must ensure equitable access to diagnosis and treatment
The African Journal of Laboratory Medicine focuses on the role of the laboratory and its professionals in the clinical and public healthcare sectors, and is specifically based on an African frame of reference.
- Open Access
- 31 January 2022
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 11 (1) , 1476
Implementation of a customised antimicrobial resistance laboratory scorecard in Cameroon, Ethiopia and Kenya
Background: In low-resource settings, antimicrobial resistance (AMR) is detected by traditional culture-based methods and ensuring the quality of such services is a challenge. The AMR Scorecard provides laboratories with a technical assessment tool for strengthening the quality of bacterial culture, identification, and antimicrobial testing procedures.Objective: To evaluate the performance of the AMR Scorecard in 11 pilot laboratory evaluations in three countries also assessed with the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) checklist.Methods: Pilot laboratory evaluations were conducted in Cameroon, Ethiopia and Kenya between February 2019 and March 2019. Assessors with previous SLIPTA and microbiology experience were trained. Assessors performed the laboratory assessments using the SLIPTA and AMR Scorecard tools.Results: Weaknesses in technical procedures and the quality management systems were identified in all areas and all laboratories. Safety had the highest mean performance score (SLIPTA: 68%; AMR Scorecard: 73%) while management review had the lowest (SLIPTA: 32%; AMR Scorecard: 8%) across all laboratories. The AMR Scorecard scores were generally consistent with SLIPTA scores. The AMR Scorecard identified technical weaknesses in AMR testing, and SLIPTA identified weaknesses in the quality management systems in the laboratories.Conclusion: Since the AMR Scorecard identified important gaps in AMR testing not detected by SLIPTA, it is recommended that microbiology laboratories use SLIPTA and the AMR Scorecard in parallel when preparing for accreditation. Expanding the use of the AMR Scorecard is a priority to address the need for quality clinical microbiology laboratory services in support of optimal patient care and AMR surveillance.
- 31 January 2022
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 11 (1) , 1476
Open AccessImplementation of a customised antimicrobial resistance laboratory scorecard in Cameroon, Ethiopia and Kenya
Background: In low-resource settings, antimicrobial resistance (AMR) is detected by traditional culture-based methods and ensuring the quality of such services is a challenge. The AMR Scorecard provides laboratories with a technical assessment tool for strengthening the quality of bacterial culture, identification, and antimicrobial testing procedures.Objective: To evaluate the performance of the AMR Scorecard in 11 pilot laboratory evaluations in three countries also assessed with the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) checklist.Methods: Pilot laboratory evaluations were conducted in Cameroon, Ethiopia and Kenya between February 2019 and March 2019. Assessors with previous SLIPTA and microbiology experience were trained. Assessors performed the laboratory assessments using the SLIPTA and AMR Scorecard tools.Results: Weaknesses in technical procedures and the quality management systems were identified in all areas and all laboratories. Safety had the highest mean performance score (SLIPTA: 68%; AMR Scorecard: 73%) while management review had the lowest (SLIPTA: 32%; AMR Scorecard: 8%) across all laboratories. The AMR Scorecard scores were generally consistent with SLIPTA scores. The AMR Scorecard identified technical weaknesses in AMR testing, and SLIPTA identified weaknesses in the quality management systems in the laboratories.Conclusion: Since the AMR Scorecard identified important gaps in AMR testing not detected by SLIPTA, it is recommended that microbiology laboratories use SLIPTA and the AMR Scorecard in parallel when preparing for accreditation. Expanding the use of the AMR Scorecard is a priority to address the need for quality clinical microbiology laboratory services in support of optimal patient care and AMR surveillance.